Brief: Y-mAbs Therapeutics Reports Q4 net income USD 1.2 million
30/03/2023 21:02
Mar 30 (Reuters) - Y-mAbs Therapeutics Q4 net income USD 1.2 million. * Q4 product revenue USD 16.4 million
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary